Mygdalon en es it fr

Mygdalon Brand names, Mygdalon Analogs

Mygdalon Brand Names Mixture

  • No information avaliable

Mygdalon Chemical_Formula


Mygdalon RX_link

Mygdalon fda sheet

Mygdalon FDA

Mygdalon msds (material safety sheet)

Mygdalon MSDS

Mygdalon Synthesis Reference

Thominet, U.S. Pat. 3,177,252 (1965)

Mygdalon Molecular Weight

299.796 g/mol

Mygdalon Melting Point

147.25 oC

Mygdalon H2O Solubility

200 mg/L

Mygdalon State


Mygdalon LogP


Mygdalon Dosage Forms

Liquid; Syrup; Tablet

Mygdalon Indication

For the treatment of gastroesophageal reflux disease (GERD)

Mygdalon Pharmacology

Metoclopramide, although chemically related to procainamide, does not possess local anesthetic or antiarrhythmic properties. Metoclopramide is used to enhance GI motility, to treat diabetic gastroparesis, as an antinauseant, and to facilitate intubation of the small bowel during radiologic examination. Metoclopramide may be used to treat chemotherapy-induced emesis and as a radiosensitizing agents in the treatment of non-small cell lung carcinoma and glioblastomas in the future.

Mygdalon Absorption

Rapidly and well absorbed (oral bioavailability 80±15.5%).

Mygdalon side effects and Toxicity

Oral, mouse LD50: 280 mg/kg. Signs of overdose include drowsiness, disorientation, and extrapyramidal reactions.

Mygdalon Patient Information

Mygdalon Organisms Affected

Humans and other mammals